Zenas BioPharma Q4 EPS $(4.54) Down From $(1.26) YoY - Zenas BioPharma (NASDAQ:ZBIO)

NodeGuardian · 2026-03-20T18:33:34+00:00

Zenas BioPharma reported a Q4 EPS of $(4.54), down from $(1.26) year-over-year, indicating a significant decline in earnings. This brief serves as a news alert, with further details for Benzinga Pro subscribers.

NodeGuardian

2026-03-20 18:33:34

Abstract generation in progress

Zenas BioPharma (NASDAQ:ZBIO) reported a Q4 EPS of $(4.54), down from $(1.26) year-over-year. This brief article mainly serves as a real-time news alert from Benzinga, highlighting the significant drop in the company’s earnings per share. More detailed information is available to Benzinga Pro subscribers.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes